RNA interference against MDM2 suppresses tumor growth and metastasis in pancreatic carcinoma SW1990HM cells
- 326 Downloads
In our previous study, the mouse double minute 2 (MDM2) was identified as one of the leading genes that promote the metastasis of pancreatic cancer (PC). However, the mechanism by which MDM2 promotes metastasis of PC is not understood. In this study, we show that down-regulation of MDM2 through lentivirus-mediated RNA interference could also suppress in vitro proliferation and in vivo tumor growth, and led to an obvious inhibition of both in vitro invasion and in vivo live metastases of SW1990HM cells which had an over-expression of MDM2 and a higher metastatic potential. Moreover, we also show that the down-regulation of MDM2 induced a significant decrease in MMP9, Ki-67 and increase in P53, E-Cadherin expression, and results in an altered expression of genes involved in metastasis, apoptosis, and cell proliferation. Our results suggest that MDM2 plays an important role in metastasis as well as tumor growth of PC. MDM2 could be a hopeful target for the control of PC.
KeywordsPancreatic cancer Cell line MDM2 RNA interference Liver metastasis
The authors thank Jianming Luo, Department of Breast Surgery, of the Breast Cancer Institute, Fudan University, for their help with this study. We also thank Lixin Chen for his help with the animal experiments.
Conflict of interest
The authors declare that they have no competing interests.
- 7.Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che MX, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A (2009) MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92–02. J Clin Oncol 27:3177–3184PubMedCrossRefGoogle Scholar
- 15.Yang JY, Zong CS, Xia WY, Wei YK, Ali-Seyed M, Li Z, Broglio K, Berry DA, Hung MC (2006) MDM2 promotes cell motility and invasiveness by regulating E-Cadherin degradation. Mol Biol 26(19):7269–7282Google Scholar
- 19.Zhou GQ, Zhai Y, Cui Y, Zhang XM, Dong XJ, Yang H, He Y, Yao KT, Zhang HX, Zhi LT, Yuan XY, Qiu W, Zhang XA, Shen Y, Qiang BQ, He FC (2007) MDM2 Promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 13(9):2627–2633PubMedCrossRefGoogle Scholar